176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-73.68%
Negative net income growth while MRVL stands at 26.89%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
16.48%
Some D&A expansion while MRVL is negative at -3.32%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-81.97%
Both reduce yoy usage, with MRVL at -301.06%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
25.31%
Some inventory rise while MRVL is negative at -21.87%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
-130.90%
Both reduce yoy usage, with MRVL at -39.29%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
939.59%
Growth of 939.59% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
-145.79%
Both yoy CFO lines are negative, with MRVL at -15.40%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
64.71%
Some CapEx rise while MRVL is negative at -110.78%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-0.89%
Both yoy lines negative, with MRVL at -0.64%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
150.46%
We have some liquidation growth while MRVL is negative at -30.74%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
859.57%
We have mild expansions while MRVL is negative at -137.18%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-18.03%
Negative yoy issuance while MRVL is 48.59%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.